Fed. Circ. Reverses Rejection Of Psoriasis Drug Patent
The Federal Circuit on Friday overturned the U.S. Patent and Trademark Office's rejection of claims in an inventor's patent application for a psoriasis treatment, finding the office failed to support its...To view the full article, register now.
Already a subscriber? Click here to view full article